You can still find small-cap superstars
Small-cap superstars still abound

There are some picks in this sector that have excellent valuations and strong earnings growth.


Most investors in the precious metal should avoid ETFs and focus instead on these picks.

By TheStockAdvisors Jul 11, 2012 2:19PM
Image: Gold Bars (© Stockbyte/SuperStock)By Curtis Hesler, Professional Timing Service

Seasonally, gold is often ho-hum during the first six months of the year, only to set a low in July and extend strongly on the up side into October.

If I were short, I'd be anxious about the next "black swan" event that could propel gold suddenly higher. I'd also be apprehensive about that seasonal strength and concerned that there is an important cyclical low due right about now. 

Agricultural plays and gun makers are performing exceptionally well right now.

By Jul 11, 2012 1:58PM

Image: Combines in field (© Mark Karrass/Corbis/Corbis)By Kate Stalter,

In this interview, investing coach Gennady Kupershteyn shares some ideas for sectors showing technical and fundamental strength. In addition to some agricultural stocks, he discusses tech, health care, gun makers, and consumer discretionary names.

Kate Stalter: Today, I'm speaking with one of our frequent guests here on the Daily Guru, Gennady Kupershteyn of Capitalist Bull.


Though this time, the $740 mark from UBS seems reasonable -- in two years.

By InvestorPlace Jul 11, 2012 1:48PM

Apple logo copyright Beck Diefenbach/ReutersBy Jeff Reeves

Another analyst is kicking off coverage of Apple (AAPL), this time at UBS (UBS). The $740 12-month price target for the tech stock and a "buy" rating is the latest vote of confidence for Apple.


I know, I know -- more nonsense about Apple price targets. These things are the hype machine of tech analysts and frequently are just silly figures to get attention.


Stocks have been sliding after a dramatic end-of-June surge. Here's why the uptrend isn't finished yet.

By Anthony Mirhaydari Jul 11, 2012 1:29PM

Stocks have been suffering bouts of panic selling over the past few days as concerns about the future of the new plan to use eurozone bailout funds to directly recapitalize weak banks (such as those in Spain) dampened spirits. German ratification of the plan will be delayed by the country's constitutional court for as long as three months, according to reports in Der Spiegel.
Some better industrial production data out of Europe and rumors of additional policy easing by the People's Bank of China weren't enough to overcome those worries. Have the four consecutive losses (with a fifth possible on Wednesday) opened the door to a new medium-term downtrend? Or is this merely a buying dip within a larger uptrend?


Stocks are mixed as investors await the release of minutes from June's Federal Reserve meeting.

By MSN Money Partner Jul 11, 2012 1:28PM
Information provided by

Fertilizer stocks, including Potash Corp. (POT), Mosaic (MOS) and CF Industries (CF), moved up modestly after the USDA slashed its forecast for corn yields.

Goldcorp (GG) slumped nearly 10% after the company reported lower than expected second-quarter gold production and reduced its full-year production guidance. Its announcement weighed a bit on peers, including Barrick Gold (ABX), Newmont Mining (NEM) and Yamana Gold (AUY). 

Despite introducing new merchandising and pricing policies, the retailer continues to stumble.

By Benzinga Jul 11, 2012 1:13PM
Image: Woman shopping in interior design shop, side view © Alistair Berg/Digital Vision/Getty ImagesBy Brett Callwood, Benzinga Staff Writer

Department store operator JC Penney (JCP) will likely see second-quarter sales fall more than the 20% witnessed during the first-quarter.

According to MarketWatch, the company has attempted to overhaul merchandising and pricing, but the efforts have failed to bring in customers.


Amazon's tablet made a splashy entrance and even managed to eat into the iPad's wide lead. But could the e-tail giant do the same with a smartphone?

By Jul 11, 2012 11:41AM

Image: logo © EMMANUEL DUNAND/AFP/Getty ImagesFirst came the Kindle Fire. Now Amazon (AMZN) is reportedly working with manufacturer Foxconn to develop its own smartphone, which would presumably take a cue from the Seattle-based e-tailer's popular line of Kindle tablets. The move is seen as Amazon's attempt to upset Apple (AAPL) and Google's (GOOG) goals in the digital content market by locking consumers into its robust catalog of e-books, movies, and mp3s -- even though the phone will likely run on something similar to the already-established Android platform.

But while the low-cost Kindle Fire was a rousing success, critics say that building a smartphone is an entirely different kind of beast, and Amazon would be wise to stay away.


Allegiant Travel is upgraded to 'buy,' and Dendreon is downgraded to 'underperform.'

By MSN Money Partner Jul 11, 2012 11:20AM
Information provided by

Wednesday's noteworthy upgrades include:  
  • Allegiant Travel (ALGT) upgraded to Buy from Hold at Deutsche Bank
  • SAP (SAP) upgraded to Buy from Hold at ThinkEquity
  • Wendy's (WEN) upgraded to Outperform from Neutral at Wedbush
  • AMC Networks (AMCX) upgraded to Positive from Neutral at Susquehanna

Coca-Cola will be the first blue chip since 2005 to divide its shares. What are splits, and why should investors care?

By Minyanville Jul 11, 2012 10:53AM

It's stupid. If you own 10 shares at $40, or one share at $400, it's the same thing! You just need to know how to divide.

--Larry Page


In light of his oft-cited quotation above, it was more than a little ironic to see Google's (GOOG) co-founder recently reverse himself and back the search giant's first stock split since it went public eight years ago. Page had nothing to say regarding his about-face, having conveniently lost his voice for the occasion, but the de facto 2-for-1 split was especially contentious, as it effectively consolidated his power, involving as it did the creation of a Class C stock that is devoid of voting rights.


Page is not the only high-profile investor to speak out on stock splits. None other than Warren Buffett rhetorically asked shareholders in a 1983 letter: "Could we really improve our . . . group by trading some present clear-thinking members for impressionable new ones who, preferring paper to value, feel wealthier with nine $10 bills than with one $100 bill?"


One of the stronger long-term stocks has sharply lowered its guidance, which means we could see a rash of it over the next few weeks.

By Jul 11, 2012 10:47AM

By Jim Jubak,


This is what I'm afraid second-quarter earnings season is going to look like for even the best of companies: On Tuesday, Cummins (CMI) lowered its guidance for second-quarter revenue to $4.45 billion. The Wall Street consensus was $5.07 billion in revenue before the announcement.


For the full 2012 year, the company said it now expects that revenue will be flat with 2011. The company had hung tough until today, saying previously that it expected revenue to grow 10% in 2012 from last year.


The move is a big bet that states will allow for Medicaid expansion.

By InvestorPlace Jul 11, 2012 10:32AM

Susan Aluise


When news broke on Monday that WellPoint (WLP) would buy the Medicaid-focused insurer Amerigroup (AGP) for $4.9 billion, the deal sent shock waves through the health care industry -- and AGP shares rose 38%.


By acquiring AGP at the premium price of $92 a share, WellPoint (whose shares rose about 3% on the news) is going all-in on the government-sponsored managed care market.


If a stock is up 500% in a straight line, that's a clue.

By Jim Cramer Jul 11, 2012 10:15AM

I stumbled onto a cult of true believers these last few days, not unlike the cult behind Dendreon (DNDN), the last hornet's nest I tried to navigate, and I think the consequences will be similar for both the hornets and me.


I'm talking about Arena Pharmaceuticals (ARNA), the company that has the first new diet pill approval in more than a decade.


The manufacturer of permanent birth control system announced its next-generation procedure.

By Jul 11, 2012 9:36AM

By Zacks Equity Research


Conceptus (CPTS), the manufacturer of permanent birth control system, Essure, recently announced a 60-patient clinical trial with its next-generation Essure procedure. Patient enrollment for the clinical trial has just begun in the company's two medical centers in Canada and Mexico.


The existing Essure procedure does not immediately provide permanent birth control. It instead requires the patient to wait for a period of 90 days, during which the body grows over the inserted device, thus forming a barrier that prevents the entry of sperm. Therefore, during this 90-day period there is a need to use some other form of contraceptive.

Tags: CPTS

UBS initiates the iPhone maker with a 'buy,' and the bank is reportedly planning to reclaim stock compensation from executives involved in the trading scandal.

By MSN Money Partner Jul 11, 2012 8:57AM

By Michael Baron,

Apple (AAPL)

UBS initiated coverage of Apple with a "buy" rating and a 12-month price target of $740, saying it sees the release of the iPhone 5 as another positive catalyst for the stock, which it views as being reasonably priced.

"Apple is creating a tech empire that likely has not reached its zenith," the firm said. "Our Wave Principle teaches that empires don't last. We recommend the stock, however, because the relatively low valuation seems to discount a too-pessimistic future given moderate smartphone and tablet penetration as well as potential new products."


Behind the usual public relations waffle there are real benefits for both partners.

By Minyanville Jul 10, 2012 4:08PM

"Strategic alliances" in business often come to nothing more than a few dutiful emails floating between office cubicles. This is especially true when no cash changes hands, or when they're created to put an end to a legal dispute that one side didn't want and the other regrets.


Both of the above are true in this case, but the latest deal announced by Facebook (FB) and Yahoo (YHOO) might actually come to much more than that because both sides need it badly.



Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.


StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

114 rated 1
278 rated 2
474 rated 3
641 rated 4
639 rated 5
663 rated 6
640 rated 7
499 rated 8
284 rated 9
122 rated 10

Top Picks

TAT&T Inc9

Trending NOW

What’s this?



Quotes delayed at least 15 min


Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.


There’s a problem getting this information right now. Please try again later.
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] The major indices are sporting modest gains as the morning session continues.  All in all, there hasn't been any sense of urgency in today's trading.  That could be owed to the realization that there are some key events at the back end of the week (i.e., central bank meetings and August employment report) and/or the need for participants to re-acclimate to things after being out on vacation.

The influential sources of sector support in the early going include the ... More


There’s a problem getting this information right now. Please try again later.